nmbr1 the main point i was trying to make about NV
Post# of 148186
( which judging by your reaction I didn't articulate well ) is
both NVAX and CYDY are up about 1000%+ from there lows in the
last year and imo CYDY has FAR FAR more potential to
continue to appreciate higher from here than NVAX even with
a current mkt cap twice the size of NVAX, because of the MANY
uses leronlimab could get approval for in the many months ahead.